2-Bromo-5-Chloro-1,3-Thiazole

In the synthesis of late-stage fungicidal actives, 2-Bromo-5-Chloro-1,3-Thiazole functions as a critical halogenated building block where the bromine atom at the 2-position serves as the primary electrophilic handle in Suzuki-Miyaura cross-coupling sequences, while the chlorine at the 5-position is retained through multiple downstream transformations to modulate lipophilicity and oxidative metabolic stability in the final agrochemical scaffold. Processing campaigns across multiple campaign scales at contract manufacturing organizations have demonstrated that the electronic interplay between these two halogens imposes a pronounced regioselectivity window during palladium-catalyzed coupling: oxidative addition of Pd(0) into the C–Br bond proceeds with a selectivity exceeding 20:1 over the C–Cl bond when using Pd(PPh₃)₄ at catalyst loadings between 0.5 mol% and 2.0 mol% in THF/water biphasic systems at 55–60 °C, but this selectivity collapses to approximately 3:1 when the reaction temperature drifts above 68 °C or when the aqueous phase pH falls below 8.5, conditions under which oxidative addition to the C–Cl bond becomes kinetically competitive and generates bis-coupled impurity profiles that exceed the 0.15% threshold specified in FAO Specification 408/TC for technical-grade active ingredients. Downstream production campaigns integrate this intermediate into the synthesis of commercial SDHI (succinate dehydrogenase inhibitor) fungicides where the intact thiazole ring contributes essential hydrogen-bond acceptor geometry to the pharmacophore binding pocket. Batch records from kilo-lab and pilot-plant campaigns indicate that the heterocyclic ring itself exhibits limited thermal stability in the presence of strong aqueous bases; scouting studies document ring-opening degradation exceeding 2.5% when the intermediate is exposed to 2M NaOH at temperatures above 40 °C for more than 4 hours, a constraint that dictates the use of milder carbonate bases in the coupling step and imposes a maximum holding time of 90 minutes for the post-reaction quench prior to extractive workup. Regulatory compliance for active ingredients derived through this route falls under EU Regulation 1107/2009 for plant protection products, with residue limits governed by Regulation (EC) No 396/2005; the thiazole intermediate itself, as a non-isolated building block consumed entirely in the subsequent step, is managed under the process impurity provisions of SANCO/10597/2015 rather than requiring discrete registration. Terminal products manufactured using this bromochloro thiazole scaffold include fluxapyroxad-type carboxamide fungicides applied at field rates between 50 g/ha and 150 g/ha on cereal and oilseed crops, with the chlorine substituent specifically noted in structure-activity relationship literature as enhancing phloem mobility and prolonging residual activity beyond 21 days in wheat leaf tissue.

Electrophilic Partner Reactivity in Cross-Coupling: Avoiding Protodebromination During Scale-Up

The utilisation of 2-Bromo-5-Chloro-1,3-Thiazole in industrial palladium-catalyzed C–C bond-forming reactions within pharmaceutical intermediate supply chains requires meticulous control over the competing protodebromination pathway, a side reaction wherein the aryl bromide undergoes reductive dehalogenation by hydride transfer from the boronic acid coupling partner or from alcoholic solvent components rather than participating in the desired transmetallation event. Production-scale campaigns on 500-gallon glass-lined reactors have quantified this competition: under standard Suzuki conditions employing Pd(dppf)Cl₂·CH₂Cl₂ at 1.2 mol% in toluene/ethanol at reflux, protodebrominated by-product (5-chlorothiazole) accumulates to 3–5 area% by GC when the boronic acid is added as a single solid charge at the outset, whereas segmented addition of the boronic acid in 4 equal portions at 30-minute intervals while maintaining the internal temperature strictly within the 62–65 °C band suppresses this impurity to below 0.8 area%. The mechanism of this suppression is understood as a kinetic effect: maintaining a low steady-state concentration of free boronic acid minimizes the rate of the deleterious hydride-transfer pathway relative to the desired transmetallation, a principle that has been codified in internal process development reports but is not widely captured in published synthetic methodology papers that typically report only optimized flask-scale conditions. Manufacturing deviations from this segmented addition protocol have resulted in batch rejections where the protodebrominated impurity carried through two subsequent synthetic steps and crystallized with the final API, necessitating costly re-pulping operations in isopropanol/water mixtures at 0 °C that reduced overall yield by 6–8 percentage points. The bromochloro thiazole coupling partner is typically employed at a molar ratio of 1.0:1.05 (thiazole:boronic acid) across pharmaceutical intermediate campaigns, with the slight excess of boronic acid compensating for the unavoidable protodebromination that occurs even under optimized segmented addition. Relevant quality standards for the coupled intermediate include ICH Q3A thresholds for unspecified impurities (not exceeding 0.10% at a maximum daily dose of ≤2 g/day) and ICH Q3C residual solvent limits for the toluene/ethanol system (Class 2 toluene limited to 890 ppm). The terminal drug substances accessed through this chemistry encompass kinase inhibitors and other ATP-competitive oncology agents where the chloro-substituted thiazole motif has been demonstrated in X-ray co-crystal structures to engage a conserved backbone amide in the hinge region via a sulfur-mediated hydrogen bond, with the chlorine atom occupying a narrow lipophilic pocket that would be sterically inaccessible to larger substituents.

Production of brominated flame retardant (BFR) intermediates from 2-Bromo-5-Chloro-1,3-Thiazole exploits the synergistic flame-quenching contributions of bromine and chlorine within a single heterocyclic scaffold, a design principle that reduces the total molar halogen loading required to achieve a given UL 94 V-0 classification relative to formulations relying on a single halogen species alone. Compounding trials on co-rotating twin-screw extruders with L/D = 40:1 (ZSK Mc¹⁸ or equivalent) have mapped the process window for incorporating this halogenated thiazole into high-impact polystyrene (HIPS) matrices at melt temperatures between 190 °C and 215 °C, a range bounded on the low end by incomplete dispersion of the thiazole additive and on the high end by the onset of thermal dehydrohalogenation that generates corrosive HBr and HCl vapors detectable in the vent stream by online FTIR at concentrations exceeding 5 ppm. The addition rate ranges from 8 wt% to 14 wt% relative to the polymer matrix, with the specific loading within this band determined by the wall thickness of the injection-molded part: thinner sections below 1.5 mm demand loadings at the upper end of the range to compensate for reduced char-layer thickness, while thicker sections above 3.0 mm achieve UL 94 V-0 at loadings as low as 9 wt% when the thiazole is co-formulated with antimony trioxide at a halogen-to-metal molar ratio of 3:1. A critical processing constraint emerges from the rheological impact of the thiazole additive: melt flow index measured per ISO 1133-1:2022 at 200 °C/5 kg decreases from a baseline of 8.2 g/10 min for the neat HIPS resin to 3.1 g/10 min at 14 wt% loading, a reduction that necessitates increasing injection pressures by 15–20% and can trigger short-shot defects in molds with flow-length-to-wall-thickness ratios exceeding 150:1. Compliance with the Restriction of Hazardous Substances (RoHS) Directive 2011/65/EU is maintained provided the thiazole additive does not contain decaBDE or other restricted polybrominated species above the 0.1% homogeneous material threshold; documentation requirements under IEC 62321-8:2017 for screening of brominated substances in polymers apply. The terminal products incorporating this halogenated thiazole are enclosure components for consumer electronics, electrical connector housings, and wire insulation where the combination of bromine and chlorine within a single molecule provides a condensed-phase flame-retardant mechanism via halogen radical trapping (Br• and Cl•) in the gas phase and char promotion in the solid phase.

When the Thiazole Ring Serves as a Latent Corrosion Inhibitor in Hydrocarbon Processing Streams

Inhibition of naphthenic acid corrosion in crude oil distillation units operating at atmospheric and vacuum conditions represents a functional application of 2-Bromo-5-Chloro-1,3-Thiazole where the heterocyclic nitrogen and sulfur atoms coordinate to iron surfaces while the halogen substituents modulate the film persistence under high-temperature, high-shear flow regimes. Formulation into corrosion inhibitor packages is carried out at active concentrations between 25 ppm and 150 ppm by volume relative to the hydrocarbon stream, with the dosing rate adjusted according to the total acid number (TAN) of the crude slate as determined by ASTM D664-18e2: crudes with TAN values below 0.5 mg KOH/g require dosing at the lower end of the range, while opportunistic processing of high-TAN crudes with values exceeding 2.0 mg KOH/g demands continuous injection at rates approaching 120–150 ppm to maintain surface film integrity at metal skin temperatures that can reach 400 °C on the radiant-section tubes of the atmospheric heater. Field data from refinery trials have documented a critical threshold phenomenon: inhibitor film persistence drops precipitously when the flow velocity at the pipe wall exceeds 30 m/s, a condition encountered in transfer-line sections immediately downstream of the atmospheric resid draw-off, and under these shear conditions the bromochloro thiazole must be co-formulated with a phosphate ester synergist at a thiazole-to-phosphate weight ratio of 1:2 to prevent film stripping and localized corrosion rates measured by electrical resistance probes exceeding 0.5 mm/year. The NACE MR0103 standard for materials resistant to sulfide stress cracking in corrosive petroleum refining environments governs the metallurgy of the injection quills and downstream piping, though the thiazole inhibitor itself is not directly within the scope of this standard; its compatibility with common refinery metallurgies (carbon steel, 5Cr-0.5Mo, 9Cr-1Mo) has been verified through autoclave testing per ASTM G170-06 at 316 °C in a simulated sour crude environment. Terminal products formulated with this thiazole chemistry are organic filming corrosion inhibitors applied in both continuous injection and batch-treatment programs across crude distillation, vacuum distillation, and visbreaker units, with the bromine and chlorine substituents contributing to thermal stability of the adsorbed film beyond the 300 °C threshold where many conventional imidazoline-based inhibitors undergo thermal decomposition and lose surface activity.

Inserting a bioisosteric 2-chloro-5-substituted thiazole moiety into the central scaffold of a glucokinase activator program revealed that 2-Bromo-5-Chloro-1,3-Thiazole provides a modular entry point for parallel library synthesis, where the bromine is displaced by a palette of aryl, heteroaryl, and alkynyl nucleophiles while the chlorine is retained to occupy a small hydrophobic sub-pocket identified in the enzyme's allosteric binding site by in-house crystallography at 2.1 Å resolution. In vitro metabolic stability assays using human liver microsomes (HLM) incubated at 37 °C with NADPH regeneration demonstrated that the chlorine atom at the 5-position reduces intrinsic clearance (CL_int) relative to the des-chloro analogue by a factor of 3.5×, an effect attributed by the medicinal chemistry team to the electron-withdrawing chlorine lowering the electron density of the thiazole ring and thereby disfavoring cytochrome P450-mediated epoxidation at the 4,5-double bond that was identified as the primary oxidative soft spot in the unsubstituted series. Synthesis of advanced intermediates for these programs is conducted under cGMP conditions governed by ICH Q7A, with the bromochloro thiazole coupling step positioned as a registered starting material introduction point; the batch formula requires the thiazole to be charged at 1.05 equivalents relative to the elaborated coupling partner, with the slight excess purged in the aqueous workup and controlled in the isolated intermediate to a limit of ≤0.10% per ICH Q3A. Preparation of the penultimate intermediate is carried out in DMF at 85 °C with potassium carbonate as base, and in-process HPLC monitoring is mandated at 30-minute intervals after 3 hours of reaction time to track consumption of the thiazole starting material to below 1.0 area% before proceeding to the cooling and filtration train. The drug substances emerging from this synthetic route are orally bioavailable small-molecule glucokinase activators targeting type 2 diabetes mellitus, where the chlorine atom persists in the final API structure and is designated as a non-exchangeable halogen per the ICH M7 guideline for DNA-reactive (mutagenic) impurity assessment; the bromine, fully displaced in the coupling, contributes residual inorganic bromide that is controlled in the final API by ion chromatography to a specification of ≤50 ppm.

Formulating ultraviolet-curable protective clear coats for automotive interior plastic substrates with 2-Bromo-5-Chloro-1,3-Thiazole addresses the industry requirement for a non-migratory, non-blooming photoinitiator synergist that remains chemically bound within the crosslinked acrylate network over the 10-year/150,000 km durability lifecycle specified by OEM test protocols. The bromochloro thiazole is not itself the primary photoinitiator but rather functions as a radical-generating co-agent: upon UV-A exposure in the 320–390 nm range, homolytic cleavage of the C–Br bond generates a thiazolyl radical that abstracts hydrogen from tertiary amine co-initiators in the formulation, amplifying the population of initiating radicals available for acrylate double-bond polymerization at the surface of the coating film where oxygen inhibition would otherwise suppress cure. The concentration window is remarkably narrow: at loadings below 0.3 wt% on total resin solids, the enhancement of surface cure is statistically indistinguishable from baseline formulations lacking the thiazole; at loadings above 0.8 wt%, the excess bromine atoms that do not undergo photocleavage during the 2–5 second UV exposure window remain as labile C–Br bonds in the cured film and are detectable by ion chromatography as bromide release during accelerated weathering per SAE J2527 at 2500 kJ/m², exceeding the 5 µg/cm² total halogen release limit specified by certain OEM material standards. The optimal addition band lies between 0.45 wt% and 0.65 wt%, and batch-to-batch variability in the thiazole's crystalline particle size distribution has been identified as a process variable affecting dissolution kinetics in the acrylate monomer blend: milling to a D₉₀ of ≤25 µm via air-jet milling is specified to ensure complete dissolution within the 20-minute standard mixing cycle on high-speed dispersers operating at 2000 rpm. The terminal formulations are UV-curable hard coats meeting the requirements of GMW14872 for Taber abrasion resistance (ΔHaze ≤10% after 500 cycles CS-10F wheels at 500 g load) and are applied at dry film thicknesses of 12–18 µm over polycarbonate and ABS substrates in instrument panels, center consoles, and door trim components.

What Happens to Heatset Ink Rheology When Halogenated Thiazole Replaces Conventional Photoacid Generators?

Offset lithographic ink formulations designed for high-speed sheet-fed printing at press speeds exceeding 15,000 sheets per hour exploit the controlled thermal lability of 2-Bromo-5-Chloro-1,3-Thiazole as a latent acid source that triggers the deblocking of protected isocyanate crosslinkers in the ink's binder system during passage through hot-air drying ovens at 120–140 °C. The thiazole derivative is incorporated into the ink vehicle at concentrations between 1.0 wt% and 2.5 wt% relative to the total ink formulation weight, and the precise addition within this range governs the balance between press stability (where premature acid generation during extended press runs would increase tack and cause paper picking) and drying speed (where insufficient acid liberation in the oven leaves un-crosslinked binder that smears on the delivery pile). Control of this balance is exercised through the selection of the counterion in the amine-blocked sulfonic acid co-catalyst that works in concert with the thiazole: p-toluenesulfonic acid blocked with diisopropanolamine at a 1:1 molar ratio provides an activation window where acid release is negligible at fountain solution temperatures of 20–25 °C on the press but proceeds rapidly above 110 °C in the dryer. The rheological signature of the ink on the roller train is monitored by tack measurement per ISO 12634 at 30 °C and 400 rpm, with specifications requiring tack values between 8 and 12 units: the thiazole-containing formulations consistently demonstrate slower tack build-up over 90-minute press simulation runs relative to conventional PAG (photoacid generator) formulations, an effect rationalized by the absence of UV-sensitivity in the thiazole that eliminates the incremental acid generation that would otherwise occur from ambient fluorescent lighting on the pressroom floor. The terminal ink products are high-gloss sheet-fed offset inks qualified under ISO 2846-1:2017 colorimetric specifications, and the crosslinked binder films generated via the thiazole/blocked-acid mechanism achieve methylethylketone double-rub resistance exceeding 50 cycles within 4 hours of printing, enabling immediate post-press converting operations without the 24-hour oxidative drying delay characteristic of conventional linseed-oil-based ink systems.

Employing 2-Bromo-5-Chloro-1,3-Thiazole in the manufacture of negative-tone photoresist additives for deep-UV (248 nm) and extreme-UV (13.5 nm) lithography capitalizes on the differential absorbance and photocleavage quantum yield of the C–Br bond relative to conventional photoacid generator chromophores, a property that permits its use as a sensitivity-enhancing dopant in chemically amplified resist (CAR) platforms without the unacceptable increase in optical density that accompanies higher loadings of the primary PAG. The thiazole derivative is spin-coated as a component of the resist formulation at concentrations between 0.5 wt% and 1.5 wt% of total solids, with the specific loading optimized to match the aerial image contrast of the exposure tool: higher loadings within this band provide greater sensitivity enhancement (measured as a reduction in the dose-to-size, E_size, by 10–18% at a 32 nm half-pitch node) but simultaneously degrade line-width roughness (LWR) measured by top-down SEM metrology from a baseline of 3.5 nm (3σ) to approximately 4.8 nm (3σ) at the 1.5 wt% loading, a trade-off that must be balanced against the overlay and critical dimension uniformity budgets for the specific device layer. The mechanism of sensitivity enhancement has been investigated by radiolysis pulse-probe experiments: the C–Br bond in the thiazole undergoes dissociative electron attachment with a cross-section approximately 4× higher than that of the analogous aryl bromide chromophores, attributed to the low-lying π* orbital of the thiazole ring that stabilizes the transient negative ion intermediate, and this enhanced electron-capture efficiency translates into a larger population of secondary electrons available to reduce the primary PAG and generate catalytic acid molecules within the exposed regions of the resist film. The photoresist formulations containing the bromochloro thiazole are processed under SEMI S2/S8 equipment safety standards for fab tool compatibility, and the resist waste stream is managed under the semiconductor manufacturing waste handling protocols specified in SEMI S23 for spent organic solvents and halogenated compounds.